These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 352788)

  • 41. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media.
    Chonmaitree T; Saeed K; Uchida T; Heikkinen T; Baldwin CD; Freeman DH; McCormick DP
    J Pediatr; 2003 Sep; 143(3):377-85. PubMed ID: 14517524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.
    Louvet A; Thursz MR; Kim DJ; Labreuche J; Atkinson SR; Sidhu SS; O'Grady JG; Akriviadis E; Sinakos E; Carithers RL; Ramond MJ; Maddrey WC; Morgan TR; Duhamel A; Mathurin P
    Gastroenterology; 2018 Aug; 155(2):458-468.e8. PubMed ID: 29738698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
    Mathurin P; Mendenhall CL; Carithers RL; Ramond MJ; Maddrey WC; Garstide P; Rueff B; Naveau S; Chaput JC; Poynard T
    J Hepatol; 2002 Apr; 36(4):480-7. PubMed ID: 11943418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.
    Akriviadis E; Botla R; Briggs W; Han S; Reynolds T; Shakil O
    Gastroenterology; 2000 Dec; 119(6):1637-48. PubMed ID: 11113085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of acute alcoholic hepatitis with prednisolone. 45 patients].
    Bories P; Guedj JY; Mirouze D; Yousfi A; Michel H
    Presse Med; 1987 May; 16(16):769-72. PubMed ID: 2954078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of colchicine and steroids in the treatment of alcoholic liver disease.
    Galambos JT; Riepe SP
    Recent Dev Alcohol; 1984; 2():181-94. PubMed ID: 6374780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bilirubin response to corticosteroids in severe alcoholic hepatitis.
    Morris JM; Forrest EH
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):759-62. PubMed ID: 15947554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study.
    Alvarez MA; Cabré E; Lorenzo-Zúñiga V; Montoliu S; Planas R; Gassull MA
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1375-80. PubMed ID: 15618848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.
    Vergis N; Atkinson SR; Knapp S; Maurice J; Allison M; Austin A; Forrest EH; Masson S; McCune A; Patch D; Richardson P; Gleeson D; Ryder SD; Wright M; Thursz MR
    Gastroenterology; 2017 Apr; 152(5):1068-1077.e4. PubMed ID: 28043903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prednisolone plus S-adenosil-L-methionine in severe alcoholic hepatitis.
    Tkachenko P; Maevskaya M; Pavlov A; Komkova I; Pavlov C; Ivashkin V
    Hepatol Int; 2016 Nov; 10(6):983-987. PubMed ID: 27337960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.
    Mathurin P; O'Grady J; Carithers RL; Phillips M; Louvet A; Mendenhall CL; Ramond MJ; Naveau S; Maddrey WC; Morgan TR
    Gut; 2011 Feb; 60(2):255-60. PubMed ID: 20940288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials.
    Hmoud BS; Patel K; Bataller R; Singal AK
    Liver Int; 2016 May; 36(5):721-8. PubMed ID: 26279269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.
    Porter HP; Simon FR; Pope CE; Volwiler W; Fenster LF
    N Engl J Med; 1971 Jun; 284(24):1350-5. PubMed ID: 4930603
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pentoxifylline against prednisolone in severe acute alcoholic hepatitis: a Korean trial].
    Chanson P; Pariente A
    Rev Prat; 2014 Nov; 64(9):1206. PubMed ID: 25638854
    [No Abstract]   [Full Text] [Related]  

  • 55. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial.
    De BK; Gangopadhyay S; Dutta D; Baksi SD; Pani A; Ghosh P
    World J Gastroenterol; 2009 Apr; 15(13):1613-9. PubMed ID: 19340904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study.
    Blitzer BL; Mutchnick MG; Joshi PH; Phillips MM; Fessel JM; Conn HO
    Am J Dig Dis; 1977 Jun; 22(6):477-84. PubMed ID: 326034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis.
    Mezey E; Potter JJ; Rennie-Tankersley L; Caballeria J; Pares A
    J Hepatol; 2004 Jan; 40(1):40-6. PubMed ID: 14672612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone.
    Mathurin P; Duchatelle V; Ramond MJ; Degott C; Bedossa P; Erlinger S; Benhamou JP; Chaput JC; Rueff B; Poynard T
    Gastroenterology; 1996 Jun; 110(6):1847-53. PubMed ID: 8964410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis.
    Kulkarni K; Tran T; Medrano M; Yoffe B; Goodgame R
    J Clin Gastroenterol; 2004; 38(5):453-9. PubMed ID: 15100527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity.
    Dhanda AD; di Mambro AJ; Hunt VL; McCune CA; Dayan CM; Dick AD; Lee RW; Collins PL
    Hepatology; 2015 Mar; 61(3):1099. PubMed ID: 24811769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.